AGT and COVID-19: In many cases, the use of ACEi and angiotensin receptor blockers (ARBs) effectively re-establish RAAS homeostasis by reducing Ang II pathophysiological signalling and unsurprisingly, these mechanisms may reduce the progression of severe COVID-19 [40].